Reslizumab (Cinqair): An Interleukin-5 Antagonist for Severe Asthma of the Eosinophilic Phenotype
P T
.
2017 Sep;42(9):564-568.
Authors
Selina Hom
,
Michele Pisano
PMID:
28890642
PMCID:
PMC5565129
Abstract
Reslizumab (Cinqair), an interleukin-5 antagonist for severe eosinophilic asthma.